Systemic Juvenile Idiopathic Arthritis (SJIA) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
Systemic juvenile idiopathic arthritis, also termed as systemic-onset juvenile idiopathic arthritis, is a specific form of juvenile idiopathic arthritis. SJIA was also known as Still's disease. With symptoms of arthritis systemic juvenile idiopathic arthritis also shows extra-articular expression like rashes and fever. All types of arthritis involve chronic inflammation in the joints. Symptoms that last from six weeks to three months are termed chronic. Juvenile idiopathic arthritis can affect one or many joints and it can cause other symptoms such as eye inflammation. Systemic juvenile idiopathic arthritis affects around 10% children with arthritis. SJIA starts with high fever which can be 103 °C or higher, and fever can be recurring. Salmon colored rashes could also appear and disappear. Apart from inflammation of joints, SJIA can cause inflammation on internal organs. Joint inflammation may not appear until months or even after a year the fever starts. Increased white blood cells count and anemia (low red blood cells count) are also typical symptoms of SJIA. Arthritis like symptoms may present even after the fever and other symptoms disappeared.
The global SJIA market is projected to grow at a rapid pace due to increase in prevalence of SJIA globally, also due to the available treatment and awareness between peoples are some other factors boosting the market growth. According to the Arthritis Foundation, nearly 3,000,000 children are suffering from SJIA in the U.S. A research paper published by the U.S. National Library of Medicine on SJIA, the prevalence of JIA in North America and Europe ranges from 16 to 150, and 2 to 20, per 100,000, respectively. In countries in the West, oligoarthritis is the most common sub type of JIA, while predominance of polyarthritis is more common in counties such as South Africa, New Zealand, India, and Costa Rica. A large number of children suffer from SJIA in Asia Pacific. Enthesitis-related arthritis (ERA), another sub-type of JIA, is the most common type of JIA in Canada, Mexico, and India. Rise in awareness about SJIA and available treatment is another factor boosting market growth. However, drug resistance and presence of large number of market players are the major restraints of the global systemic juvenile idiopathic arthritis treatment market.
The global systemic juvenile idiopathic arthritis treatment market can be segmented based on type of treatment, end-user, and region. In terms of type of treatment, the market can be classified into NSAIDs, corticosteroids and cyclophosphamide, cyclosporine, thalidomide, and biologics. The biologics segment can be sub-segmented into IL-1 inhibitors (anakinra, rilonacept, and canakinumab), tocilizumab, abatacept, antitumor necrosis factors antibodies (anti-TNF), and rituximab. Based on end-user, the global market can be categorized into hospitals, orthopedic center, and others.
In terms of region, the global systemic juvenile idiopathic arthritis treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global market due to availability of advanced medications. Awareness among the people about the diseases is another factor boosting the market in this region. The systemic juvenile idiopathic arthritis treatment market in Asia Pacific is anticipated to expand at a high growth rate due to increase in prevalence of the disease. Lack of awareness about the disease in the underdeveloped countries in Middle East & Africa such as Turkey, Cyprus, Syria, Lebanon, and Iraq drives the systemic juvenile idiopathic arthritis treatment market.
Key players operating in the global systemic juvenile idiopathic arthritis treatment market are Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Sanofi, F. Hoffmann-La Roche Ltd., and Amgen Inc., among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017